We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-3.2%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$745B
AUM Growth
+$33.9B
Cap. Flow
-$10.6B
Cap. Flow %
-1.43%
Top 10 Hldgs %
31.69%
Holding
14,193
New
1,741
Increased
5,205
Reduced
5,319
Closed
1,559

Top Buys

Rank Stock Value
1
ZM icon
Zoom
ZM
+$834M
2
FDX icon
FedEx
FDX
+$666M
3
MSFT icon
Microsoft
MSFT
+$594M
4
AMD icon
Advanced Micro Devices
AMD
+$585M
5
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$403M

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.17B
2
AMZN icon
Amazon
AMZN
+$1.98B
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.79B
4
NVDA icon
NVIDIA
NVDA
+$1.18B
5
WFC icon
Wells Fargo
WFC
+$827M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.63%
2 Technology 1.89%
3 Consumer Discretionary 1.29%
4 Communication Services 0.93%
5 Healthcare 0.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ILLM
11526
PUT
DELISTED
illumin Holdings Inc. Common Shares
ILLM
$183K ﹤0.01%
+27,300
New +$223K
FNHC
11527
DELISTED
FedNat Holding Company Common Stock
FNHC
$183K ﹤0.01%
73,918
-28,952
-28% -$76.4K
VGII.U
11528
DELISTED
Virgin Group Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fifth
VGII.U
$183K ﹤0.01%
18,453
– –
MACK
11529
CALL
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$183K ﹤0.01%
+37,900
New +$198K
YDKG
11530
Yueda Digital Holding
YDKG
$5.7M
$182K ﹤0.01%
173
+49
+40% +$49.5K
AVTX icon
11531
CALL
Avalo Therapeutics
AVTX
$1.08B
$182K ﹤0.01%
29
+10
+53% +$81.1K
BMRA icon
11532
CALL
Biomerica
BMRA
$6.49M
$182K ﹤0.01%
5,063
+1,450
+40% +$47.7K
VS icon
11533
Versus Systems
VS
$8.51M
$182K ﹤0.01%
206
+159
+338% +$176K
NTRP icon
11534
PUT
NextTrip
NTRP
$20.7M
$182K ﹤0.01%
2,970
-6,820
-70% -$468K
WMPN
11535
DELISTED
William Penn Bancorporation Common Stock
WMPN
$182K ﹤0.01%
+14,894
New +$180K
BLRX
11536
PUT
BioLineRX
BLRX
$12.1M
$181K ﹤0.01%
+1,655
New +$196K
CPARU
11537
DELISTED
Catalyst Partners Acquisition Corp. Unit
CPARU
$181K ﹤0.01%
18,372
– –
IEC
11538
CALL
DELISTED
IEC Electronics Corp.
IEC
$181K ﹤0.01%
+11,800
New +$155K
KRNY icon
11539
CALL
Kearny Financial
KRNY
$650M
$180K ﹤0.01%
+14,500
New +$179K
OPRA
11540
PUT
Opera Ltd
OPRA
$1.73B
$180K ﹤0.01%
20,300
-20,900
-51% -$203K
JNCE
11541
PUT
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$180K ﹤0.01%
24,200
-80,500
-77% -$499K
KLDO
11542
CALL
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$180K ﹤0.01%
+32,900
New +$204K
OSG
11543
PUT
Octave Specialty Group
OSG
$203M
$179K ﹤0.01%
12,500
-33,000
-73% -$471K
FBIO icon
11544
Fortress Biotech
FBIO
$93.4M
$179K ﹤0.01%
3,698
+431
+13% +$21K
MVO
11545
CALL
DELISTED
MV Oil Trust
MVO
$179K ﹤0.01%
+20,600
New +$152K
ZVO
11546
CALL
DELISTED
Zovio Inc. Common Stock
ZVO
$179K ﹤0.01%
75,000
+6,300
+9% +$15.6K
CPSS icon
11547
CALL
Consumer Portfolio Services
CPSS
$202M
$178K ﹤0.01%
30,500
+2,600
+9% +$13.7K
NGL icon
11548
NGL Energy Partners
NGL
$2.19B
$178K ﹤0.01%
74,910
-222,014
-75% -$433K
PHIO icon
11549
CALL
Phio Pharmaceuticals
PHIO
$13M
$178K ﹤0.01%
816
-106
-11% -$22.1K
VISL
11550
CALL
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$178K ﹤0.01%
4,915
-2,570
-34% -$111K
460 461
462
463 464

Similar funds

Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jeff Yass's Q3 2021 Portfolio in Review

As of Q3 2021, Jeff Yass held 14,193 positions worth $745B, up 4.8% from $712B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q3 2021 filing shows 1,741 new, 5,205 increased, 5,319 reduced and 1,559 closed positions. Its largest new stake was InMode: 613,660 shares worth $48.9M. The largest sale was Walt Disney, an estimated $2.17B.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q3 2021 buy was InMode: 613,660 shares worth $48.9M.
  • Jeff Yass added most to Zoom in Q3 2021, an estimated $834M increase.
  • Jeff Yass's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $2.17B.
  • Jeff Yass fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $103M.
  • Jeff Yass's ten largest holdings make up 32% of its $745B portfolio in Q3 2021.
  • Jeff Yass opened 1,741 new positions and closed 1,559 in Q3 2021.
  • Jeff Yass's portfolio value rose 4.8% quarter-over-quarter to $745B.

Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.